Ledger.Open graph →
SEC Form D · Amendment · filed August 17, 2018

Prelude Therapeutics Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wilmington, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Juan Luengo · Newark, DEExecDavid Bonita · Montreal, Quebec, CanadaDirectorPaul Friedman · New York, NYDirectorKelvin Neu · San Francisco, CADirectorKrishna Vaddi · Chadds Ford, PAExec · DirectorJuan Luengo · Newark, DEExecDavid Bonita · New York, NYDirectorPaul Friedman · San Francisco, CADirectorKelvin Neu · Newark, DEDirectorKrishna Vaddi · Chadds Ford, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗